- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
Insights 22 results
Client Alert
March 19, 2025
France Adopts a Law Banning PFAS in Cosmetics, Textiles, and Waxing Products
Client Alert
February 28, 2025
Europe’s new Clean Industrial Deal to accelerate decarbonization, reindustrialization and innovation
Client Alert
October 4, 2024
Blue Hydrogen and Ammonia: EU’s Rules for Low Carbon Fuels Released for Consultation
Thought Leadership
September 6, 2024
Salomé Cisnal de Ugarte Appointed as Non-Governmental Advisor (NGA) to the European Commission at the International Competition Network (ICN)
Client Alert
Article · Source: Law360
August 6, 2024
A Primer On EU's Updated Human Substance Regulations
Article · Source: The Guide to Life Sciences - Second Edition
October 20, 2023
European Union: Commission Intensifies Merger Review Focus on Pipeline Products and Pay-for-Delay Cases in the Spotlight
Client Alert
September 5, 2023
EU regulatory challenges complicating the development of international green hydrogen projects
Client Alert
July 6, 2023
EUROPE – New Interim Guidance on Parallel EMA-HTA Body Scientific Advice
Client Alert
June 21, 2023
Europe's Definition of Green Hydrogen (RFNBO) Adopted into EU Law
Client Alert
May 3, 2023
EUROPE – Revision of EU General Pharmaceutical Legislation
Client Alert
March 27, 2023
With Risk Comes Responsibility: EU Proposes High-Risk AI Regulation Affecting Device Manufacturers